Science and Research Content

American Society for Cell Biology selects TEMIS for Science Navigator application -

TEMIS, a provider of Semantic Content Enrichment solutions for the Enterprise, has announced an extension of their collaboration with the American Society for Cell Biology (ASCB) to further hone the ASCB Science Navigator, a bespoke version of TEMIS Luxid Navigator - Biopharma Edition, as a tool for biomedical research. The ASCB Science Navigator aggregates information from millions of scientific documents and news releases, providing scientists working in basic biomedical research with an efficient, one-stop shop where they can discover insights to drive their research.

ASCB is an inclusive, international community of biologists studying the cell, the fundamental unit of life. ASCB is dedicated to advancing scientific discovery, advocating sound research policies, improving education, promoting professional development, and increasing diversity in the scientific workforce.

The ASCB Science Navigator is based on the 2014 CODiE Award-winning Luxid Navigator, TEMIS's user-friendly SaaS analytics application that helps scientists explore and then target pertinent information. Based on a dashboard approach, Luxid Navigator leverages advanced computational linguistics to dynamically build intuitive visualization widgets that with a few clicks, help users find information that would otherwise have taken hours or days to collate.

The ASCB's customized application uses some of the Luxid® Navigator's specific search lenses on key areas of interest such as identifying experts; science of diseases and their treatment; and updated literature and news in areas of interest.

Luxid Navigator also includes other dedicated search lenses like Clinical Trial Intelligence and Drug Safety modules that enable professionals to gauge the competition's trials pipelines and optimise their clinical trials, with a better understanding and awareness of relationships between drugs, reactions, patient populations.

Click here to read the original press release.

STORY TOOLS

  • |
  • |

sponsor links

For banner ads click here